|Articles|March 25, 2011
March 2011 Vol XXVIII No 3 - Psychiatric Times
Advertisement
Open publication
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
NDA Submission: Olanzapine Extended-Release Injectable Suspension for Treatment of Schizophrenia
2
Transcranial Magnetic Stimulation in Sports Performance: Promise, Physiology, and Precaution
3
Semaglutide Potentially Protective Against Nephrotoxicity Caused by Lithium
4
FDA Accepts NDA for TRN-257 for Treatment of Narcolepsy and Idiopathic Hypersomnia
5










